Status:
COMPLETED
Micropulse Transscleral Diode Laser Cyclophotocoagulation (MP-TSCPC) as a Treatment Modality for Glaucoma Patients
Lead Sponsor:
Benha University
Conditions:
Glaucoma
Eligibility:
All Genders
3-70 years
Phase:
NA
Brief Summary
The study objective was to evaluate the efficacy and safety of transscleral cyclophotocoagulation (TSCPC) using micropulse diode laser treatment in patients with various types of glaucoma.
Detailed Description
Evaluation of the efficacy and safety of a new form of transscleral cyclophotocoagulation (TSCPC) using micropulse diode laser treatment in patients with various types of glaucoma. In this study, 810 ...
Eligibility Criteria
Inclusion
- Patients previously diagnosed with glaucoma if they had uncontrolled Intraocular pressure despite maximal tolerated medical therapy.
- Patients who are unable to maintain compliance with the prescribed topical medications.
- Patients who need filtering glaucoma surgery for controlling Intraocular pressure but are not generally fit for the surgery.
- Patients who refused incisional procedures like subscleral trabeculectomy.
Exclusion
- Patients who were unable to give informed consent.
- Patients who had undergone previous conventional transscleral diode laser cyclophotocoagulation (TSCPC).
- Patients with significant scleral thinning defined as thinning of more than one clock hour noticed on scleral transillumination.
- Patients with ongoing ocular infection or inflammation.
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05299281
Start Date
January 1 2020
End Date
July 1 2021
Last Update
March 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Benha University
Banhā, Other, Egypt, 13511